Peculiarities and Consequences of Different Angiographic Patterns of STEMI Patients Receiving Coronary Angiography Only: Data from a Large Primary PCI Registry

Table 2

Univariate analysis of selected study subgroups and cardiovascular risk factors.

	(a) Takotsubo (OR, 95% CI)	(b) Distal embolisation (OR, 95% CI)	(c) MINOCA (OR, 95% CI)	(d) Myocarditis (OR, 95% CI)	(e) CABG–referred patients (OR, 95% CI)	(f) Normal coronary arteries (OR, 95% CI)	(g) Others (OR, 95% CI)
Age >70	0.5 (0.11–2.26)	3.14(1.25–6.37)	1.13 (0.66–1.99)	∞ (1.74–∞)	0.50(0.33–0.76)	1.25(1.01–1.56)	0.33 (0.08–1.23)
Female gender	0.57 (0.13–2.54)	1.26 (0.75–2.18)	1.26 (0.76–2.14)	∞ (1.92–∞)	0.74 (0.54–1.02)	2.66(1.4–4.78)	0.39 (0.09–1.39)
Smoking	0.98 (0.19–4.17)	3.19(1.91–5.32)	3.01(1.82–4.9)	21.17(2.76–62.19)	4.15(2.93–5.86)	2.76(1.72–4.41)	1.08 (0.27–3.92)
Diabetes mellitus	2.45 (0.42–62.55)	1.15 (0.67–2.07)	6.9(4.2–11.4)	1.39 (0.42–6.44)	1.12(1.07–1.68)	1.9(1.07–3.60)	1.49 (0.36–10.84)
Dyslipidemia	2.32 (0.55–12.09)	5.1(2.96–8.84)	0.38(0.20 –0.66)	18.73(2.44–14.3)	5.5(3.9–7.9)	1.25(1.2–2.1)	0.96 (0.23–3.47)
Hypertension	∞ (1.86–∞)	2.83(1.65–4.86)	3.02(1.77–5.16)	∞(3.64–∞)	1.9(1.3–2.64)	7.74(3.96–15.14)	9.68(1.24–17.8)
Chronic kidney disease	0.36 (0.08–1.86)	1.41 (0.73–3.09)	5.06(1.58–16.19)	∞ (0.73–∞)	0.90 (0.61–1.37)	2.66(1.15–6.17)	1.76 (0.32–43.96)
LVEF <35%	0.31 (0.07–1.41)	3.42(1.92–5.12)	0.79 (0.47–1.37)	3.69 (0.73–89.99)	2.62(1.9–3.63)	0.90 (0.54–1.55)	0.32 (0.09–1.18)

Statistically significant, at least.